Human medicines European public assessment report (EPAR): Vazkepa, icosapent ethyl, Dyslipidemias, Date of authorisation: 26/03/...
Vazkepa is a medicine for reducing the risk of cardiovascular events such as heart attack, stroke and other problems caused by blocked blood circulation. It is for use as add-on treatment in adults being treated with a statin medicine who have high levels …